GGC, PWRM, RSG, GRHU, GTY - Stock News & Alerts for Jan. 17th, 2011

Georgia Gulf Corp. (NYSE:GGC) announced that it has amended and extended its $300 million Asset Based Loan (ABL) agreement with its lenders. The amended agreement will mature in January 2016, two years later than the previous agreement. The interest rate on the agreement was reduced from a range of LIBOR plus 325-400 basis points to a range of LIBOR plus 250-300 basis points.

Additionally, the $15 million availability block in the previous agreement was removed and the overall fee structure was reduced.

Georgia Gulf Corporation engages in the manufacture and marketing of chlorovinyl and aromatics chemicals, as well as vinyl-based building and home improvement products in the United States and internationally.

Power3 Medical Announces Update on Upcoming Acquisition of Rozetta-Cell Life Sciences

Power3 Medical Products, Inc. (PWRM.OB), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, this morning announced that company management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer's and Parkinson's, to name a few.

In addition, Power3 is a party to several litigation matters, most of which relate to various toxic debt instruments that were entered into by Power3 several years ago when it operated under the tenure of Chairman and CEO, Steven B. Rash. Because current management believes these toxic debt instruments are responsible for Power3's depressed stock price and have distracted the company from its mission, Power3 plans to settle as many of these nagging lawsuits as possible prior to the completion of its merger with Rozetta-Cell Life Sciences, Inc.

As for those lawsuits that cannot be speedily resolved, Power3 will continue to rigorously defend its position. For example, one such lawsuit involves Neogenomics, Inc., which was recently granted a motion for summary judgment with respect to an amount due under a convertible debenture. Power3 intends to appeal this decision.

"We are very excited to be finally ridding ourselves of litigation that has plagued us for several years now," stated Ira L. Goldknopf, President and Chief Scientific Officer of Power3 Medical Products, Inc.

"We have big plans for the future beginning with our upcoming acquisition of Rozetta-Cell and are about to enter a long and substantial growth phase marked by advances in our science and intellectual property. Given the imminent nature of many of these transactions and breakthroughs, we have decided, in consultation with the financiers of Rozetta-Cell, that the best course of action for Power3 is to settle many of these lawsuits so that we can focus our attention exclusively on the acquisition of Rozetta-Cell and the development of our combined businesses after the merger."

Rozetta-Cell Life Sciences, Inc. is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. Power3 plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company. The acquisition of Rozetta-Cell is expected to be completed in February 2011.

Power3 Medical Products

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

Learn more, visit PWRM at : http://www.Power3Medical.com

_____

Republic Services, Inc. (NYSE:RSG) announced fourth quarter and year-end earnings on Februrary 10, 2011. Investors are invited to listen to the Company's investor conference call that will be broadcast live over the Internet on Thursday, February 10, 2011 at 5:00 p.m. Eastern Time. Interested parties may also dial into the conference by calling 210-234-0084.

The pass code for the call is “Republic Services.” Please dial in ten minutes prior to the start of the call. A telephone recording of this call will be available through February 17, 2011. To access the replay, call: 402-220-9769 Passcode: 4293.

Replays are generally available one hour after a call ends. The conference call will be archived on Republic's web site at www.republicservices.com (click on “Investor Information”).

Republic Services, Inc. provides nonhazardous solid waste collection, transfer, and disposal services in the United States.

_____

GreenHouse Holdings, Inc. (OTCQB:GRHU) a leading provider of energy efficiency solutions and sustainable infrastructure products, announced that it has been engaged to implement Southern California Edison's (SCE) Automated Demand Response (Auto-DR) program for two industrial customers. The customers are Apogee Containers, Inc. and MGE UPS, LLC.

GreenHouse estimates that the projects will generate $400,000 in revenue for GreenHouse, based upon approximately 1,300 kW or 1.3 MW of electricity demand reduction and infrastructure improvements from the engagements. GreenHouse is a qualified service provider of SCE's Auto-DR program, providing site assessment, feasibility studies, project development, engineering, and installation of enabling technologies including complete processing of all utility documents.

The Auto-DR program offers significant financial incentives and technical support to Southern California Edison (SCE) customers willing to install equipment that enables participation in demand response events versus depending on their employees to perform all the curtailment activities manually when required.

Normally, control systems (automation) are installed with the programming needed to achieve reductions in electricity consumption during peak periods of demand on the grid. “Participants in SCE's Auto-DR program are in 100% control of the actual curtailment measures implemented on an event-to-event basis. By utilizing an Auto-DR system, participants will have real-time usage information and the technical means to reduce electric consumption during costly peak energy periods when the demand is highest.

On-going financial benefits can be realized from program enrollment and DR event participation (benefits vary from program to program). Additionally, the systems commonly implemented for Auto-DR participation are fully capable of being used to improve productivity and equipment operating efficiencies as well as provide users with information that can augment routine and emergency operations and maintenance regimens,” adds Robert Davis, Vice President of Energy Services at GreenHouse.

GreenHouse Holdings, Inc. is a leading provider of energy efficiency solutions and sustainable infrastructure products. The company designs, engineers and installs disparate products and technologies that produce persistent technical and financial results, by enabling clients to monitor and control their energy costs in the most efficient manner possible.

Its target markets for energy efficiency solutions include residential, commercial and industrial, as well as government and military markets. In addition, the company develops, designs and constructs rapidly deployable, sustainable infrastructure primarily for use in disaster relief and security in austere regions.

_____

Getty Realty Corp. (NYSE:GTY) announced that it has completed the acquisition of 59 Mobil branded gasoline station and convenience store properties located in and around northern suburbs of New York City (including Westchester and Rockland Counties) and the lower Hudson Valley, funding a total investment of $111,300,000.

The 59 properties were acquired in a simultaneous transaction among ExxonMobil, CPD NY Energy Corp. (a subsidiary of Chestnut Petroleum Distributors) and Getty Realty Corp.

Getty Realty Corp. operates as a real estate investment trust (REIT) in the United States. The company engages in the ownership and leasing of retail motor fuel and convenience store properties, and petroleum distribution terminals.

_____

*************************************************************

For FREE Daily Stock Alerts & Updates Signup At: http://pennytobuck.com/signup

*************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer (http://pennytobuck.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyToBuck.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

Crown Equity Holdings Inc. (CRWE.OB) has received ten thousand dollars in cash and anticipates another ten thousand dollars in cash from the company for 60 days of advertisement services for Green House Holdings, Inc. (GRHU). In addition to the cash, Crown Equity Holdings Inc. (CRWE.OB) also anticipates receiving 20,000 shares of 144 restricted stocks from a third party.